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Abstract 
Objectives: Clinical trial registration is widely recommended, since it allows tracking of trials 
that helps ensure full and unbiased reporting of their results. Aim of the present overview was to provide 
empirical evidence on bias associated with trial registration via a meta-epidemiological approach. 
Study Design and Settings: Six databases were searched in September 2017 for randomized 
clinical trials and systematic reviews thereof assessing the effects of orthodontic clinical interventions. 
After duplicate study selection and data extraction, statistical analysis included a two-step meta-
epidemiological approach within- and across-included meta-analyses with a Paule-Mandel random-
effects model to calculate Differences in Standardized Mean Differences (ΔSMD) between registered and 
unregistered trials and their 95% Confidence Intervals (CI), followed by subgroup and sensitivity 
analyses. 
Results: A total of 16 meta-analyses with 83 trials and 4988 patients collectively were finally 
included, which indicated that registered trials reported less beneficial treatment effects than 
unregistered trials (ΔSMD=-0.36; 95% CI=-0.60,-0.12). Although some small-study effects were identified, 
sensitivity analyses according to precision and risk of bias indicated robustness. 
Conclusions: Signs of bias from lack of trial protocol registration were found with non-registered 
trials reporting more beneficial intervention effects than registered ones. Caution is warranted by the 
interpretation of non-registered randomized trials or systematic reviews thereof. 
 
Keywords: Randomized clinical trials; Protocol registration; Empirical bias; Meta-analysis; Meta-
epidemiology 
 
 
 
  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
3 
 
Manuscript 
1. Introduction 
1.1. Background 
Randomized clinical trials are regarded as the gold standard in comparative efficacy research and 
form the basis for translating research evidence to clinical practice [1]. Among their advantages, 
methodological transparency is crucial and entails registration of the trial design protocol in a public 
domain prior to trial initiation in order to improve accountability in the conduct and reporting of 
research [2]. Trial protocols can be used post hoc to compare the original plan with subsequent 
procedures and analyses [3], thereby potentially reducing the risk of data dredging. A priori trial 
registration can additionally safeguard against bias-related phenomena such as delayed publication or 
non-publication of trials, selective reporting of outcomes, manipulation of the analysis plan, and counting 
covert duplicate publications within systematic reviews as separate trials [3-6]. 
Insights on trial characteristics systematically associated with treatment effects can be gleamed 
through meta-epidemiological studies. This is a subgenre of the big family of overviews of reviews, 
wherein data from a collection of meta-analyses is integrated and classified according to a specific study-
level trait in order to empirically assess its influence on treatment effects [7]. 
A recent comprehensive meta-epidemiological study reported that non-registered or 
retrospectively registered trials tend to show larger treatment effects [8]. Although the effect was not 
statistically significant, this is confirmed by cross-sectional overviews of randomized trials in cardiology 
[9] or general medicine [10] that report weak associations between positive findings and trial 
registration, although the effects were not always consistent. It is also important to note that these 
analyses were based on qualitative evaluations of trial results by using either a P value cut-off or the 
trialists’ interpretation of the results in text, both of which can be problematic. 
 
1.2. Scope 
The aim of this meta-epidemiological study is to provide empirical evidence of possible 
differences in the results of registered and non-registered randomized clinical trials in orthodontics as a 
sign of bias, including its direction and magnitude. 
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2. Methods 
2.1. Protocol, eligibility criteria, and registration 
The protocol for this overview of reviews and trials was made a priori based loosely on the 
format of a systematic review, registered in PROSPERO (CRD42017072043), and all post hoc changes to 
the protocol were appropriately noted. According to the criteria set a priori, eligibility included parallel 
randomized clinical trials (or meta-analyses thereof) on human patients on any experimental 
intervention compared to a conventional or control group with any binary/continuous outcome in 
orthodontics and dentofacial orthopedics. Excluded were non-clinical studies, animal studies, and non-
randomized studies. Split-mouth (within-person) randomized clinical trials were excluded as the 
suboptimal reporting of such studies in orthodontics makes their integration in meta-epidemiological 
synthesis difficult [11, 12]. Additionally, only ‘hard’ outcomes pertaining to overall treatment success, 
treatment duration, or treatment adverse effects were included, because these can easily be categorized 
as beneficial/detrimental and are empirically more robust than surrogate outcomes [13]. Ultimately, only 
meta-analyses of at least three trials, including at least one registered and at least one non-registered trial 
were included so that meta-epidemiological effects can be estimated. This meta-epidemiological study is 
loosely conducted and reported according to guidelines for systematic reviews and overviews thereof [1, 
7, 14]. 
 
2.2. Information sources and literature search 
The literature search for this study was done in two steps. Initially data from a recent study [15] 
that searched the ClinicalTrials.gov and the ISRCTN registries were used to identify all orthodontic 
subjects with at least one registered randomized trial (Supplementary Table 1). Then, separate literature 
searches were performed for all identified subjects in order to identify eligible registered or non-
registered randomized trials or systematic reviews with meta-analyses, including at least one randomized 
trial. A total of six electronic databases (MEDLINE through Pubmed, Cochrane Database of Systematic 
Reviews, Cochrane Central Register of Controlled Trials, Cochrane Database of Abstracts of Reviews of 
Effects, Web of Knowledge, and Scopus) were searched systematically by one author (SNP) without any 
limitations from inception up to September 2nd, 2017 (Supplementary Table 2). Four additional sources 
(Scopus, Google Scholar, ClinicalTrials.gov, and ISRCTN registry) were manually searched for additional 
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trials. No limitations concerning language, publication year or status were applied. All identified relevant 
systematic reviews with meta-analysis were manually searched for additional trials. 
 
2.3. Study selection, data collection, and risk of bias in individual studies 
The titles and abstracts of all studies identified by the literature searches were screened by one 
author (SNP), excluding all those obviously non-relevant according to the study scope and non-clinical 
studies. The remaining full texts were checked for eligibility by one author (SNP) with a subsequent 
duplicate independent checking in full by another author (GMX), while conflicts were resolved by the last 
two authors (MTC, TE). All identified randomized trials were separately checked for eligibility on study 
design, intervention, and outcome. All meta-analyses included in identified systematic reviews were 
checked for any eligible randomized trials that could be added to a single meta-analysis without overlap 
on each topic and outcome to inform the meta-epidemiological synthesis. Trial overlaps within each 
meta-analysis and across meta-analyses were removed by assigning the Pubmed unique identifier to each 
trial and including each trial only once per meta-analysis. Where needed, interquartile ranges were 
converted to standard deviations and similar measurements concerning the same outcome (like visual 
analogue and Likert pain scales) were combined. When subgroup analyses were performed in identified 
meta-analyses, these were ignored and the overall pooled estimate was used.  
Characteristics of included meta-analysis and trials were extracted fully in duplicate by two 
authors (SNP, GMX) using pre-determined and piloted extraction forms. Extracted data included first 
author name, publication year, outcome measured, outcome data, and trial registration status. 
Registration status originated from a previous study on two trial registers [15] and was subsequently 
supplemented by reading the full text of the published paper. Missing data were requested by trialists or 
calculated from available high-quality graphs with the freely-available Web Plot Digitizer version 3.12 
(http://arohatgi.info/WebPlotDigitizer). 
The risk of bias of the included randomized trials was not planned to be comprehensively 
assessed with the Cochrane risk of bias tool [1], as this was outside the scope of this study. Only the 
adequacy of the generation of random sequence and blinding of outcome assessor was assessed 
independently by two authors (SNP, GMX) according to the Cochrane guidelines [1] as low or 
unclear/high to use this for sensitivity analyses. Differences in risk of bias between registered and non-
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registered trials were gauged with cross-tabulation and calculation of relative risks and their 95% 
Confidence Intervals (CI). 
 
2.4. Data synthesis 
As the clinical effects of orthodontic trials are bound to be influenced by appliance [16, 17], 
patient [18], or study design-related characteristics [6, 19, 20] a random-effects model was chosen a 
priori, even though no clear guidance for model choice in meta-epidemiological studies exists. The Paule-
Mandel random-effects variance estimator was preferred to the DerSimonian and Laird one, following 
recent advice [21]. 
For all included meta-analyses, the Standardized Mean Difference (SMD) was chosen as the effect 
measure because it standardizes estimates by their variability and enables overall synthesis [22]. Binary 
outcomes were planned to be converted to SMDs prior to pooling, but no eligible binary outcomes were 
identified. All outcomes were categorized as beneficial or harmful and all SMDs were recoded on the same 
direction, so that a positive SMD was beneficial. When trials with more than one experimental 
(interventional) trial arms were included, these arms were pooled prior to the meta-analysis to avoid 
double-counting of control patients. 
Random-effects meta-regression with the Paule-Mandel variance estimator was performed, fully 
incorporating heterogeneity between-trials, to derive a difference in SMDs (ΔSMD) and the standard 
error within each meta-analysis, according to registration status of included trials. Ultimately, Paule-
Mandel random-effects meta-analysis (i.e. meta-epidemiological synthesis) was used to pool the overall 
effect of trial registration across all component meta-analyses taking into account variability across them. 
The magnitude for SMDs and ΔSMD was arbitrarily assessed using Cohen’s [22] guidelines: up to 
0.2=small effect, 0.2 to 0.5=medium effect, 0.5 to 0.8=large effect, and larger than 0.8=very large effect. 
These cut-off values were also adopted to visually enhance the produced forest plot [23]. 
Absolute and relative between-meta-analyses heterogeneity/inconsistency was quantified with 
the tau² metric and the I² statistic, respectively. The latter is defined as the proportion of total variability 
in the results explained by heterogeneity, and not chance [24]. 95% CIs around all heterogeneity 
measures were calculated to quantify existing uncertainty [25], while 95% predictive intervals were to be 
calculated for the meta-epidemiological synthesis to provide a range of possible effects for a future 
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clinical setting [26]. All analyses were run in Stata SE 14.0 (StataCorp, College Station, TX) by one author 
(SNP) and all material was openly made available through Zenodo [27]. A two-tailed P-value of 0.05 was 
considered significant for hypothesis-testing, except for a 0.10 used for the test of heterogeneity and 
reporting biases, due to low power [28].  
 
2.5. Additional analyses 
Random-effects subgroup analyses were planned a priori to identify possible differences in the 
effect of trial registration among various orthodontic topics, binary versus continuous outcomes, 
subjective versus objective outcomes, and positive or negative effect direction with an interaction term by 
Paule-Mandel meta-regression. Indications of reporting biases (including small-study effects) were 
assessed with Egger’s linear regression test [29] and contour-enhanced funnel plots [30]. 
Robustness of the results to possible sources of bias or confounding was planned to be checked in 
sensitivity analyses by (i) including only meta-analyses with an arbitrary cut-off of at least 10 trials/meta-
analysis, (ii) comparing the results of fixed-effect and random-effects models, and (iii) including only the 
largest meta-analysis from each included Intervention-Control comparison. Additionally, (iv) a post hoc 
sensitivity analysis by including the 50% of meta-analyses with most included trialswas performed after 
identifying signs of small-study effects. Finally, (v) a sensitivity analysis was performed to account for 
different risk of bias for the randomization sequence generation or (vi) for the blinding of outcome 
measurement across trials by including both trial registration and bias as factors in the within-meta-
analysis meta-regression of meta-analyses with at least 5 trials, before pooling the overall effect of trial 
registration across meta-analyses. 
 
3. Results 
3.1. Study selection 
The literature search yielded a total of 1241 hits electronically and 18 hits manually as of 
September 2, 2017; 216 of which, proceeded to full text assessment after eliminating duplicates and 
ineligible studies by title or abstract (Figure 1; Supplementary Table 3a-3g). Finally, a total of 48 trials on 
similar comparisons were identified as eligible for inclusion in the present meta-epidemiological study. 
These were included in 16 separate meta-analyses on seven different topics, with some trial overlap 
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among meta-analyses. Four authors of identified studies were also contacted to request missing data 
(Supplementary Table 4), which were provided.  
 
3.2. Study characteristics 
The 16 eligible meta-analyses included a total of 83 trials with overlap (median of 3.5 trials; 
interquartile range 3 to 6 trials; range 3 to 14 trials) and a total of 4988 randomized patients (median of 
47 patients; interquartile range 30 to 60 patients; range 14 to 1000 patients). Analyzing the 
characteristics of included trials without overlap, a total of 59 published reports pertaining to 48 unique 
randomized trials were identified (Supplementary Table 5), which randomized a median of 40 patients 
(interquartile range 30 to 60 patients; range 14 to 1000 patients) to a total of 3188 patients. Among these 
48 trials, only 10 of them (20.8%) had been registered in a trial registry overall, with registered trials 
within each meta-analysis ranging from 10% to 66% (Supplemenary Table 6). A wide variety of outcomes 
were assessed in these trials including treatment duration, dental or skeletal treatment, and adverse 
effects like patient-reported pain or treatment-induced root resorption. 
 
3.3. Risk of bias within studies 
Hints of bias (i.e. systematic differences in the results) within included trials was primarily 
addressed according to their registration status. Additionally, the adequacy of the random sequence 
generation was formally assessed according to the Cochrane risk of bias tool. From the 48 identified trials, 
low risk of bias was found for the randomization sequence in 32 trials (66.7%), while the rest of the trials 
had either unclear or high risk of bias. Adequate blinding of outcome assessment was found for 15 of the 
48 (31.3%) identified trials. Registered trials were more likely to have low risk of bias for the 
randomization generation (90.0% vs 60.5%, respectively; relative risk: 1.49; 95% CI: 1.07 to 2.07) and 
more likely to have low risk of bias for blinding of outcome assessors (93.3% vs 54.6%; relative risk: 1.38; 
95% CI: 0.56 to 3.43). 
 
3.4. Results of individual meta-analyses and meta-epidemiological synthesis 
The results of all included meta-analyses including the registration status and risk of bias for 
randomization or blinding of outcome assessor can be seen in full detail in Supplementary Figure. 
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The meta-epidemiological synthesis of all 16 included meta-analyses indicated that considerable 
differences in the reported intervention effects were seen between registered and non-registered trials 
(pooled ΔSMD: -0.36; 95% CI: -0.60, -0.12; P: 0.003). This indicated that registered trials reported less 
favorable intervention effects compared to non-registered trials, which could be interpreted as signs of 
bias. Based on Cohen’s classification, this bias would be judged as of moderate magnitude. The observed 
absolute (tau2: 0; 95% CI: 0, 0.18) and relative heterogeneity (I2: 0%; 95% CI: 0%, 42%) was minimal and 
the 95% predictive intervals coincided with the 95% CIs. 
 
3.5. Additional analyses 
No robust evidence could be found for differences among subgroups according to clinical 
scenario, outcome scope, nature, or direction (Table 1). Although great variation was seen (especially for 
the different clinical scenarios), very wide 95% CI were observed, indicating imprecision due to break-up 
of the sample. 
As far as reporting biases are concerned, the funnel plot gave clear signs of asymmetry, which 
were formally confirmed by Egger’s test (coefficient=-0.88; 95% CI=-1.59, -0.18; P=0.02). Based on the 
funnel plot the source of this asymmetry was taken to be small-study effects, with smaller and more 
imprecise meta-analyses reporting greater ΔSMDs. 
A number of pre-defined sensitivity analyses were performed on the main analysis (Table 2). 
Choice of statistical model or choice of only one meta-analysis per clinical scenario was not associated 
with the observed effects. Due to significant signs of small-study effects an additional post hoc sensitivity 
analysis with only the 50% largest meta-analyses was performed, which yielded identical ΔSMD. 
Additionally, a separate sensitivity analysis controlling for low or unclear/high risk of bias for the 
generation of the randomization sequence found likewise that the observed effects were robust (ΔSMDs 
of -0.36 and -0.37 for the original and adjusted analysis, respectively). Finally, a separate sensitivity 
analysis controlling for low or unclear/high risk of bias for blinding outcome assessment found that trial 
registration had considerably higher influence on the observed effects (ΔSMDs of -0.36 and -1.80 for the 
original and adjusted analysis, respectively), but caution is needed as only 3 meta-analyses contributed to 
this. 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
10 
 
4. Discussion 
4.1. Principal findings 
The present review summarizes empirical evidence up to September 2017 about the effects of 
trial registration on the results of orthodontic randomized clinical trials. Empirical evidence from 16 
meta-analyses and 4 988 patients indicated that registered trials report considerably less beneficial 
treatment effects compared to non-registered trials, which can be interpreted as signs of bias of moderate 
magnitude. The fact that bias from lack of registration was found to be of moderate magnitude must not 
be underestimated, since this source of bias can act in an additive manner together with other known 
bias-related sources, such as, inadequate randomization or baseline imbalance, lack of blinding, small 
sample size, choice of control group, and others [19, 31-36]. 
 
4.2. Comparison with other studies 
To our knowledge this is the first study to provide statistically significant empirical evidence of 
bias from lack of trial registration in an oral health field. The only study similar to ours is the 
comprehensive meta-epidemiological study from Dechartres et al. [8], who assessed Cochrane Reviews 
with binary outcomes published between 2011 and 2014. Although they included a greater number of 
meta-analyses (n=37) across various medical fields, they found a small effect indicating that non-
registered trials tended to show larger treatment effect estimates than registered trials (ratio of odds 
ratios=0.85; 95% CI=0.67-1.08), which was not statistically significant. Differences with our results could 
be explained by the inclusion in the Dechartres et al. [8] study of more heterogeneous trial outcomes than 
the present study, where only ‘hard’ outcomes were included. Additionally, Dechartres et al. [8] found 
similar magnitude of bias for non-registered versus registered trials (ratio of odds ratios of 0.85)—
although not statistically significant. Another cross-sectional overview of randomized trials found only a 
weak association between trial registration and positive study results (adjusted risk ratio of 0.87) and a 
possible variation between non-industry and industry funded trials [10], but concluded that evidence is 
inconsistent. However, it must be noted that this was a large unselected group of randomized trials across 
various research question and unstratified by disease, intervention, and outcome and therefore, a 
potentially existing effect might have been masked by the pooled analysis.  
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4.3. Strengths and limitations  
Strengths of the current study include the a priori development of a research protocol that was 
precisely followed and the detailed reporting of all post hoc choices (Appendix), which supports the 
study’s credibility [37]. Additionally, maximized data output through author communications, use of an 
improved variance estimator [21], graphical assessment of the effects’ clinical relevance with contours of 
magnitude [38], and transparent open data provision [27] can be counted among the study’s strengths. 
This study also has some limitations. First, it was based on a convenience sample limited to a 
dental specialty field, which meant that only a small number of eligible trials could eventually be included 
and that the meta-epidemiological synthesis might be potentially underpowered. Therefore, additional 
empirical evidence is needed to confirm or refute the findings of the current study. Second, as only 
studies from a single field were included, the studies results might not directly transferable to other field, 
although no rationale for this exists. Third, trial registration might be associated with many other trial 
characteristics possibly linked to bias like geographic origin, number of study centers, sample size and 
used methods, which was not considered in this study. Finally, we did not differentiate between 
randomized trials having been prospectively or retrospectively registered and we did not directly assess 
firsthand discrepancies between the trials’ published reports and protocols. These were not planned 
during protocol and it would not be possible to formally integrate those factors in the analysis, due to the 
already limited existing material. This can be the focus of future empirical studies with a wider scope. 
 
4.4. Conclusions and policy implications 
It is evident from the results of this study that trial registration, apart from being crucial to the 
transparency and credibility of a trial, can potentially influence either directly or indirectly the current 
evidence base and therefore clinical recommendations. Our findings support the the initiatives of the 
World Health Organization, the International Committee of Medical Journal Editors towards, and other 
research regulatory authorities to provide a depository for trial registration and to promote policies that 
support trial registration and adherence to reporting guidelines. The current situation of clinical trials in 
orthodontics suboptimal both in terms of registration [15] and reporting quality [39]. Efforts have been 
made from orthodontic journals to improve author adherence to the Consolidated Standards of Reporting 
Trials (CONSORT) guidelines [40]. However and even though a large part of medical journals requires all 
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submitted trials to be registered [41], only five out of the ten existing orthodontic journals only mention 
trial registration in their author instructions, while only one (Journal of Orthodontics) words this 
explicitly as a requirement for publication [15]. It is important finally to note that trial registration does 
not preclude the use of inappropriate methods or bias. 
 
4.5. Summary 
The present meta-epidemiological study provides empirical evidence of bias originating from a 
lack of protocol registration among randomized clinical trials in orthodontics and dentofacial 
orthopaedics. Therefore, caution is warranted by the interpretation of unregistered trials or by their 
incorporation in systematic reviews and clinical guidelines. However, the evidence base that was used in 
the present study is limited and future studies are expected to expand upon it. 
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Figure Legends 
Fig. 1. Flowdiagram for the identification and selection of studies in this meta-epidemiological study. 
 
Fig. 2. Contour-enhanced forest plot for the meta-epidemiological synthesis using a Paule-Mandel 
random-effects model. Results are given as ∆SMDs and their 95% CIs. ∆SMD, standardized mean 
difference; CI, confidence intervals. 
 
Fig. 3. Contour-enhanced funnel plot plot summarizing for the meta-epidemiological synthesis. 
∆SMD, standardized mean difference. 
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Supplementary data 
Supplementary data related to this article can be found at: 
 
Supplementary Table 1 List of identified registered, completed, and published trials in orthdontics 
(from PMID 28777820). 
Supplementary Table 2 Literature searches performed on 15 August 2017 for the identification of 
registered or unregistered trials and systematic reviews/meta-analyses thereof for each of the 
eligible fields. 
Supplementary Table 3a List of included/excluded studies on the topic of self-ligating brackets. 
Supplementary Table 3b List of included/excluded studies on the topic of vibration as adjunct. 
Supplementary Table 3c List of included/excluded studies on the topic of piezocision. 
Supplementary Table 3d List of included/excluded studies on the topic of maxillary protraction for 
maxillary deficiency. 
Supplementary Table 3e List of included/excluded studies on the topic of skeletal anchorage for 
space closure. 
Supplementary Table 3f List of included/excluded studies on the topic of gum as adjunct. 
Supplementary Table 3g List of included/excluded studies on the topic of low level light therapy. 
Supplementary Table 4 Communcations with trialists to request data. 
Supplementary Table 5 Charecteristics of included trials. 
Supplementary Table 6 Details of included meta-analyses. 
Supplementary Figure Forest plots for meta-analyses included in meta-epidemiological synthesis. 
Appendix Post hoc changes to the protocol. 
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Table 1. Mixed-effects subgroup analyses of the meta-epidemiological synthesis. Negative effects indicate that registered trials show less beneficial treatment 
effects. 
Factor Category Meta-analyses ∆SMD (95% CI) P* 
Clinical scenario Active vs passive self-ligating brackets for comprehensive treatment 1 -0.38 (-1.81,1.04) 
0.39 
 Maxillary protraction vs untreated control for maxillary deficiency 3 -0.96 (-1.66,-0.27) 
 Chewing gum vs no chewing gum for comprehensive treatment 1 -2.06 (-5.55,1.42) 
 Light therapy versus no light therapy for comprehensive treatment 1 -0.37 (-5.71,4.98) 
 
Temporary anchorage devices vs conventional anchorage for anchorage 
reinforcement during extraction treatment 3 -0.56 (-1.40,0.29) 
 Self-ligating brackets vs conventional brackets for comprehensive treatment 6 -0.22 (-0.52,0.08) 
 Vibration adjuncts vs no vibration adjuncts for comprehensive treatment 1 -0.23 (-1.27,0.82) 
     
Outcome scope Treatment efficacy 12 -0.51 (-0.83,-0.19) 
0.11 
 Adverse effects 4 -0.17 (-0.53,0.19) 
 
    
Outcome nature Objective 13 -0.46 (-0.75,-0.17) 
0.15 
 Subjective (patient reported pain) 3 -0.14 (-0.56,0.29) 
  
   
Outcome directiona Negative is favorable intervention effect 12 -0.29 (-0.59,-0.00) 
0.40 
 Positive is favorable intervention effect 4 -0.49 (-0.90,-0.07) 
Abbreviations: ∆SMD, difference in standardized mean differences; CI, confidence interval. 
a
 this pertains to initial direction of outcome. Outcomes were uniformly transformed on the same direction to pool. 
* for between-subgroup differences. 
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Table 2. Sensitivity analyses of the meta-epidemiological synthesis. Negative effects indicate that registered trials show less beneficial treatment 
effects. 
Analysis Meta-analyses ∆SMD (95% CI) P 
Original analysis 16 -0.36 (-0.60,-0.12) 0.003 
    
(i) Fixed effect model 16 Same as original 
 (ii) Only the largest meta-analysis of each Intervention-Control comparison 
included 7 -0.30 (-0.63,0.02) 0.06 
(iii) 50% of meta-analyses with most included trials 8 -0.36 (-0.71,-0.00) 0.05 
(iv) Meta-analyses with ≥ 10 included trials 2 -0.94 (-2.09,0.22) 0.11 
(v) Analysis adjusted for risk of bias due to inadequate random sequence 
generationa 6 -0.37 (-0.79,0.05) 0.09 
(vi) Analysis adjusted for risk of bias due to inadequate outcome blindingb 3 -1.80 (-3.54,-0.06) 0.04 
Abbreviations: ∆SMD, difference in standardized mean differences; CI, confidence interval. 
a
 Only meta-analyses with ≥5 trials were included in this. Both registration status and low (or unclear/high) risk of bias for random sequence 
generation were used within each meta-analysis to calculate ∆SMDs, which were afterwards pooled across meta-analyses. 
b
 Only meta-analyses with outcomes that could be blinded were included. Both registration status and low (or unclear/high) risk of bias for blind 
outcome measurement were used within each meta-analysis to calculate ∆SMDs, which were afterwards pooled across meta-analyses. 
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meta-epidemiological study 
 
What is new? 
 
Key findings 
• Registered randomized trials in orthodontics report less beneficial treatment effects than 
unregistered ones. 
• The magnitude of bias from lack of trial registration was robust to small study effects and trial 
risk of bias. 
 
What this adds to what was known? 
• There appears to be a systematic difference in the results between randomised and non-
randomised trials in orthodontics, with a trend for the former to report less beneficial treatment 
effects 
• These findings are highly relevant to the interpretation of existing biomedical literature and 
ongoing trial registration incentives from editors and research regulatory authorities. 
• Empirical evidence indicates that various characteristics pertaining to the design and conduct of 
randomized trials lead to exaggerated effect estimates. 
• It is believed that a priori trial registration can safeguard against reporting bias. 
• This is to our knowledge the first study to definitely show empirical bias arising from non-
registration of randomized trials. 
 
What is the implication and what should change now? 
• Estimates coming from non-registered randimzed randomized trials or meta-analyses thereof 
should be interpreted with caution. 
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